BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22027741)

  • 1. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression.
    Kayser G; Sienel W; Kubitz B; Mattern D; Stickeler E; Passlick B; Werner M; Zur Hausen A
    Pathology; 2011 Dec; 43(7):719-24. PubMed ID: 22027741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer.
    Földi M; Stickeler E; Bau L; Kretz O; Watermann D; Gitsch G; Kayser G; Zur Hausen A; Coy JF
    Oncol Rep; 2007 Apr; 17(4):841-5. PubMed ID: 17342325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.
    Langbein S; Zerilli M; Zur Hausen A; Staiger W; Rensch-Boschert K; Lukan N; Popa J; Ternullo MP; Steidler A; Weiss C; Grobholz R; Willeke F; Alken P; Stassi G; Schubert P; Coy JF
    Br J Cancer; 2006 Feb; 94(4):578-85. PubMed ID: 16465194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TKTL-1 expression in lung cancer.
    Fritz P; Coy JF; Mürdter TE; Ott G; Alscher MD; Friedel G
    Pathol Res Pract; 2012 Apr; 208(4):203-9. PubMed ID: 22445516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1.
    Kayser G; Kassem A; Sienel W; Schulte-Uentrop L; Mattern D; Aumann K; Stickeler E; Werner M; Passlick B; zur Hausen A
    Diagn Pathol; 2010 Apr; 5():22. PubMed ID: 20385008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome.
    Lange CA; Tisch-Rottensteiner J; Böhringer D; Martin G; Schwartzkopff J; Auw-Haedrich C
    Ophthalmology; 2012 Sep; 119(9):1924-9. PubMed ID: 22658715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of heparanase activity in primary resected non-small cell lung cancer.
    Takahashi H; Ebihara S; Okazaki T; Suzuki S; Asada M; Kubo H; Sasaki H
    Lung Cancer; 2004 Aug; 45(2):207-14. PubMed ID: 15246192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.
    Hsu NY; Ho HC; Chow KC; Lin TY; Shih CS; Wang LS; Tsai CM
    Cancer Res; 2001 Mar; 61(6):2727-31. PubMed ID: 11289154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer.
    Krockenberger M; Engel JB; Schmidt M; Kohrenhagen N; Häusler SF; Dombrowski Y; Kapp M; Dietl J; Honig A
    Anticancer Res; 2010 May; 30(5):1653-9. PubMed ID: 20592357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
    Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
    Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
    Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients.
    Kato T; Daigo Y; Aragaki M; Ishikawa K; Sato M; Kondo S; Kaji M
    Lung Cancer; 2011 Oct; 74(1):124-31. PubMed ID: 21376419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
    Werle B; Kotzsch M; Lah TT; Kos J; Gabrijelcic-Geiger D; Spiess E; Schirren J; Ebert W; Fiehn W; Luther T; Magdolen V; Schmitt M; Harbeck N
    Anticancer Res; 2004; 24(6):4147-61. PubMed ID: 15736466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer.
    Staiger WI; Coy JF; Grobholz R; Hofheinz RD; Lukan N; Post S; Schwarzbach MH; Willeke F
    Oncol Rep; 2006 Oct; 16(4):657-61. PubMed ID: 16969476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression status of ribonucleotide reductase small subunits hRRM2/p53R2 as prognostic biomarkers in stage I and II non-small cell lung cancer.
    Hsu NY; Wu JY; Liu X; Yen Y; Chen CY; Chou MC; Lin CH; Lee H; Cheng YW
    Anticancer Res; 2011 Oct; 31(10):3475-81. PubMed ID: 21965764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
    Milas I; Komaki R; Hachiya T; Bubb RS; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
    Clin Cancer Res; 2003 Mar; 9(3):1070-6. PubMed ID: 12631609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases.
    Zerilli M; Amato MC; Martorana A; Cabibi D; Coy JF; Cappello F; Pompei G; Russo A; Giordano C; Rodolico V
    Cancer; 2008 Sep; 113(5):936-44. PubMed ID: 18615628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer.
    Jung CK; Jung JH; Park GS; Lee A; Kang CS; Lee KY
    Pathol Int; 2006 Sep; 56(9):503-9. PubMed ID: 16930330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.